2018 annual financial data
Rigel Pharmaceuticals 2018 Operating margin
Direct answer
Operating margin was -163.3%.
Operating income was -72,683,000 USD and net income was -70,480,000 USD.
Operating cash flow was -58,826,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44,509,000 USD
- Operating income
- -72,683,000 USD
- Net income
- -70,480,000 USD
- Operating cash flow
- -58,826,000 USD